NXP900 trials for Lung cancer

All NXP900 trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying NXP900 for Lung cancer

• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
  NCT05873686 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
  NCT07784959 · Phase: Phase 1 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
  NCT07315113 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many trials study NXP900 for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.